Penicillin (PCN) allergy delabeling is an important component of antimicrobial stewardship; however, widespread implementation has lagged. We found that most patients had low-risk PCN allergy histories eligible for delabeling without skin testing. Pharmacist-led risk stratification and drug challenge expanded access to delabeling independently from an Allergy/Immunology service.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11131008 | PMC |
http://dx.doi.org/10.1017/ash.2024.91 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!